How TerrAscend is Preparing for Rescheduling

In our latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell sit down with leadership from TerrAscend (TSX:TSND) to break down Q1 2026 preliminary earnings and how they’re preparing for rescheduling.

Chairman Jason Wild and CEO Ziad Ghanem join us to walk through the numbers following their preliminary Q1 release. Revenue came in around $65.5M—slightly down quarter-over-quarter, but back to year-over-year growth. Margins? Still holding strong north of 52%. And maybe most important—this marks another quarter of positive operating cash flow in what continues to be a tough pricing environment across key markets like New Jersey. So what’s the strategy here? Are they protecting margins… or sacrificing growth?

We get into that. We also break down:

  • What’s really happening in New Jersey as pricing pressure builds
  • Maryland dynamics—retail vs wholesale
  • Pennsylvania as a potential adult-use catalyst
  • And how they’re thinking about M&A with debt pushed out to 2028

Then we shift to the bigger story… Cannabis rescheduling, and what TerrAscend is doing to prepare. Does 280E relief change capital allocation? Do they get more aggressive? Or stay disciplined? If you’re following cannabis earnings, MSO strategy, or how operators are positioning for a post-rescheduling world—this is a conversation worth watching.

The hosts and guests also discussed Terrassen’s partnership with Tyson 2.0, which recently launched in Pennsylvania and Maryland. Both Wilde and Ghannam praised Mike Tyson as a rare example of a celebrity partner who actively works to build the brand, citing his personal appearances at dispensaries, media interviews in local markets, and meetings with state officials, contrasting his involvement with the largely transactional nature of most celebrity cannabis deals.

The episode closed with discussion of the company’s disciplined approach to expansion in Ohio, and a preview of upcoming programming including Verano’s pre-market earnings call.


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More